These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 1828371

  • 1. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS.
    Biochemistry; 1991 Jun 11; 30(23):5797-805. PubMed ID: 1828371
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC.
    Eur J Biochem; 1997 Apr 15; 245(2):316-23. PubMed ID: 9151959
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
    Sun Z, Zhang PX, Wang P, Gurewich V, Shen HY, Liu JN.
    Thromb Res; 2002 Apr 15; 106(2):105-11. PubMed ID: 12182908
    [Abstract] [Full Text] [Related]

  • 6. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
    Boutaud A, Castellino FJ.
    Arch Biochem Biophys; 1993 Jun 15; 303(2):222-30. PubMed ID: 8512311
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mutagenesis at Pro309 of single-chain urokinase-type plasminogen activator alters its catalytic properties.
    Sun Z, Liu JN.
    Proteins; 2005 Dec 01; 61(4):870-7. PubMed ID: 16231330
    [Abstract] [Full Text] [Related]

  • 12. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
    Holvoet P, Laroche Y, Lijnen HR, Van Hoef B, Brouwers E, De Cock F, Lauwereys M, Gansemans Y, Collen D.
    Eur J Biochem; 1992 Dec 15; 210(3):945-52. PubMed ID: 1483477
    [Abstract] [Full Text] [Related]

  • 13. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
    Cubellis MV, Andreasen P, Ragno P, Mayer M, Danø K, Blasi F.
    Proc Natl Acad Sci U S A; 1989 Jul 15; 86(13):4828-32. PubMed ID: 2544876
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of the intrinsic activity of pro-urokinase by diisopropyl fluorophosphate is reversible.
    Liu JN, Gurewich V.
    J Biol Chem; 1995 Apr 14; 270(15):8408-10. PubMed ID: 7721734
    [Abstract] [Full Text] [Related]

  • 15. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.
    Lijnen HR, Li XK, Nelles L, Hu MH, Collen D.
    Eur J Biochem; 1992 Apr 15; 205(2):701-9. PubMed ID: 1533368
    [Abstract] [Full Text] [Related]

  • 16. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
    Kobayashi H, Schmitt M, Goretzki L, Chucholowski N, Calvete J, Kramer M, Günzler WA, Jänicke F, Graeff H.
    J Biol Chem; 1991 Mar 15; 266(8):5147-52. PubMed ID: 1900515
    [Abstract] [Full Text] [Related]

  • 17. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
    Liu JN, Pannell R, Gurewich V.
    J Biol Chem; 1992 Aug 05; 267(22):15289-92. PubMed ID: 1639775
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR, De Cock F, Collen D.
    Eur J Biochem; 1994 Sep 01; 224(2):567-74. PubMed ID: 7925373
    [Abstract] [Full Text] [Related]

  • 19. Occupancy of the cancer cell urokinase receptor (uPAR): effects of acid elution and exogenous uPA on cell surface urokinase (uPA).
    Baker MS, Liang XM, Doe WF.
    Biochim Biophys Acta; 1992 Sep 15; 1117(2):143-52. PubMed ID: 1381963
    [Abstract] [Full Text] [Related]

  • 20. Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Holmes WE, Collen D.
    J Biol Chem; 1988 Apr 25; 263(12):5594-8. PubMed ID: 2965704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.